Genmab A/S (GMAB)
33.60
-0.81
(-2.35%)
USD |
NASDAQ |
Sep 04, 16:00
33.56
-0.04
(-0.12%)
After-Hours: 20:00
Genmab Cash and Short Term Investments (Annual) : 1.715B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.715B |
| December 31, 2024 | 2.930B |
| December 31, 2023 | 4.169B |
| December 31, 2022 | 3.204B |
| December 31, 2021 | 2.957B |
| December 31, 2020 | 2.643B |
| December 31, 2019 | 1.648B |
| December 31, 2018 | 935.38M |
| December 31, 2017 | 874.58M |
| December 31, 2016 | 556.34M |
| December 31, 2015 | 508.49M |
| December 31, 2014 | 432.34M |
| December 31, 2013 | 287.58M |
| December 31, 2012 | 265.72M |
| Date | Value |
|---|---|
| December 31, 2011 | 192.24M |
| December 31, 2010 | 296.90M |
| December 31, 2009 | 246.36M |
| December 31, 2008 | 329.06M |
| December 31, 2007 | 724.21M |
| December 31, 2006 | 305.02M |
| December 31, 2005 | 198.13M |
| December 31, 2004 | 211.68M |
| December 31, 2003 | 175.46M |
| December 31, 2002 | 193.36M |
| December 31, 2001 | 191.52M |
| December 31, 2000 | 222.02M |
| December 31, 1999 | 5.267M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AbbVie, Inc. | 5.257B |
| Ascendis Pharma A/S | 723.51M |
| Zealand Pharma A/S | 2.376B |
| Bavarian Nordic A/S | 524.17M |
| Evaxion AS | 23.23M |